Suppression of inflammation by dexamethasone prolongs adenoviral vector- mediated transgene expression in the facial nucleus of the rat

Brain Research Bulletin

Volumn 47, Issue 2, 1998, Pages 133-140

  Hermens, Wim T J M C ^a,b   Verhaagen, Joost ^a,b  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adenoviral vector; Dexamethasone; Facial nucleus; Inflammation

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FACIAL NERVE NUCLEUS; GENE TRANSFER; IMMUNE RESPONSE; INFLAMMATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; STEROID THERAPY;

ADENOVIRIDAE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; DEXAMETHASONE; FACIAL NERVE; GENE EXPRESSION; GENETIC VECTORS; MACROPHAGES; MALE; MOTOR NEURONS; PONS; RATS; RATS, WISTAR; T-LYMPHOCYTES; TIME FACTORS; TRANSGENES;

EID: 0032531119     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00042-2     Document Type: Article

References (42)

1. Adesanya M.R., Redman R.S., Baum B.J., O'Connell B.C. Immediate inflammatory responses to adeno-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 7:1996;1085-1093.
2. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L.D., Perricaudet M., Peschanski M.R. Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3:1993;224-228.
3. Armentano D., Zabner J., Sacks C., Sookdeo C.C., Smith M.P., George J.A.S., Wadworth S.C., Smith A.E., Gregory R.J. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71:1997;2408-2416.
4. Bauer J., Sminia T., Wouterlood F.G., Dijkstra C.D. Phagocytic activity of macrophages and microglial cells during the coarse of acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neurosci. Res. 38:1994;365-375.
5. Bajocchi G., Feldman S.H., Crystal R. G; Mastrangeli, A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat. Genet. 3:1993;229-234.
6. Betz A.L., Coester H.C. Effect of steroid therapy on ischaemic brain oedema and blood to brain sodium transport. Acta Neurochir. Suppl. (Wien). 51:1990;256-258.
7. Byrnes A.P., Rusby J.E., Wood M.J.A., Charlton H.M. Adenovirus gene transfer causes inflammation in the brain. Neuroscience. 66:1995;1015-1024.
8. Byrnes A.P., MacLaren R.E., Charlton H.M. Immunological instability of persistent adenovirus vectors in the brain Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination . J. Neurosci. 16:1996;3045-3055.
9. Byrnes A.P., Wood M.J.A., Charlton H.M. Role of T-cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3:1996;644-651.
10. Boer G.J., Van Esseveldt K.E., Hermens W.T.J.M.C., Liu R., Verhaagen J. Longterm transgene expression in fetal rat suprachiasmatic nucleus neurografts following ex vivo adenoviral vector-mediated gene transfer. Exp. Neurol. 145:1997;536-545.
11. Caillaud C., Akli S., Vigne E., Koulakoff A., Perricaudet M., Poenaru L., Kahn A., Berwald-Netter Y. Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur. J. Neurosci. 5:1993;1287-1291.
12. Dai Y., Schwartz E.M., Gu D., Zhang W., Zarvetnick N., Verma I.M. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene Tolerization of factor IX and vector antigens allows for long-term expression . Proc. Natl. Acad. Sci. USA. 92:1995;1401-1405.
13. Davidson B.L., Allen E.D., Kozarsky K.F., Wilson J.M., Roessler B.J. A model system for in vivo gene transfer into the CNS using an adenoviral vector. Nat. Genet. 3:1993;219-223.
14. Dijkstra C.D., Döpp E.A., Joling P., Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs distinct macrophage subpopulations in the rat recognized by mononuclear antibodies ED1, ED2 and ED3 . Immunology. 54:1985;589-599.
15. Durham H.D., Lochmüller H., Jani A., Ascadi G., Massie B., Karpati G. Toxicity of replication-defective adenoviral recombinants in dissociated cultures of nervous tissue. Exp. Neurol. 140:1996;14-20.
16. Engelhardt J.F., Ye X., Doranz B., Wilson J.M. Ablation of E2a in recombinant adenoviruses improves transgene expression and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA. 91:1994;6196-6200.
17. Forbes B.A., Bonville C.A., Dock N.A. The effects of a promoter of cell differentiation and selected hormones on human cytomegalovirus infection using an in vitro cell system. J. Infect. Dis. 162:1990;39-45.
18. Geddes B.J., Harding T.C., Hughes D.S., Byrnes A.P., Lightman S.L., Conde G., Uney J.B. Persistent transgene expression in the hypothalamus following stereotactic delivery of a recombinant adenovirus Suppression of the immune response with cyclosporin . Endocrinology. 137:1996;5166-5169.
19. Gilgenkrantz H., Duboc D., Juillard V., Couton D., Pavirani A., Guillet J.G., Briand P., Kahn A. Transient expression of genes in vivo into heart using first-generation adenoviral vectors role of the immune response . Gene Ther. 6:1995;1265-1274.
20. Gorziglia M.I., Kadan M.J., Yei S., Lim J., Lee G.M., Luthra R., Trapnell B.C. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70:1996;4173-4178.
21. Hermens W.T.J.M.C., Giger R.J., Holtmaat A.J.G.D., Dijkhuizen P.A., Houweling D.A., Verhaagen J. Transient gene transfer to neurons and glia analysis of adenoviral vector performance in the CNS and PNS . J. Neurosci. Meth. 71:1997;85-98.
22. Hermens W.T.J.M.C., Verhaagen J. Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T-cell deficient nude rats preferential survival of transduced astroglial cells in nude rats . Hum. Gene Ther. 8:1997;1049-1063.
23. Hünig T., Wallny H.J., Hartley J.K., Lawertzky A., Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J. Exp. Med. 169:1989;73-86.
24. Jones N., Shenk T. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci USA. 76:1979;3665-3669.
25. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-154.
26. Karpati G., Lochmuller H., Nalbantoglu J., Durham H. The principles of gene therapy for the nervous system. Trends Neurosci. 19:1995;49-54.
27. Le Gal La Salle G., Robert J.J., Berrard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M. ; Mallet. J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
28. Lowenstein, P. R.; Wilkinson, G. W. G.; Castro, M. G.; Shering, A. F.; Fooks, A. R.; Bain, D. Non-neurotropic adenovirus: a vector for gene transfer to the brain and possible gene therapy of neurological disorders. In: Latchman, D., ed. Genetic manipulation of the nervous system, Academic press;1996:11-39.
29. McCown T.J., Xiao X., Li J., Breese G.R., Samulski R.J. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713:1996;99-107.
30. McCoy R.D., Davidson B.L., Roesler B.J., Huffnagle G.B., Janich S.L., Laing T.J., Simon R.H. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6:1995;1553-1560.
31. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
32. Paul C., Bolton C. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int. J. Immunopharmacol. 17:1995;497-503.
33. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;London LTD, Academic press, Inc.
34. Peel A.L., Zolotukhin S., Schrimsher G.W., Muzyczka N., Reier P.J. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther. 4:1997;16-24.
35. Sabaté, O; Horrelou, P.; Vigne, E.; Colin, P.; Perricaudet, M.; Buc-Canon, M. H.; Mallet, J. Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat. Genet. 9:256-260; 1995.
36. Tanaka J., Ogura T., Kamiya S., Yoshie T., Yabuki Y., Hatano M. Dexamethasone enhances human cytomegalovirus replication in human epithelial cell cultures. Virol. 136:1984;448-452.
37. Van Esseveldt K.E., Liu R., Hermens W.T.J.M.C., Verhaagen J., Boer G.J. Adenoviral vector-mediated gene transfer and neurotransplantation approaches, possibilities and limitations in suprachiasmatic nucleus grafting . J. Neurosci. Meth. 71:1997;113-124.
38. Wood M.J.A., Charlton H.M., Wood K.J., Kajiwara K., Byrnes A.P. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 19:1996;497-501.
39. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407-4411.
40. Yang Y., Li Q., Ertl H.C., Wilson J.M. Cellular and humoral immune response to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
41. Yei S., Mittereder N., Wert S., Whitsett J.A., Wilmott R.W., Trapnell B.C. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5:1994;731-744.
42. Zsengeller Z.K., Wert S.E., Hull W.M., Hu X., Yei S., Trapnell B.C., Whitsett J.A. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6:1995;457-467.